NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ExSight Ventures

ExSight Ventures

New York City, New Yorkexsightventures.com

Overview

ExSight Ventures is a returns-oriented, mission-focused life sciences venture capital firm that specializes in early-stage investments in innovative ophthalmic diagnostic and treatment solutions. The firm was established to address the lack of early-stage funding for life science companies and is led by a team that includes two accomplished retinal surgeons, leveraging their deep domain expertise. It invests in pre-seed to Series B rounds, focusing on therapeutics, devices, and diagnostics within the eye care sector.

Portfolio Companies

10

Investments

ExSight Ventures investments
CompanyDateStageLead
RevOpsis TherapeuticsSep 2025VC RoundLead
InflammX TherapeuticsJan 2025Series ACo-investor
Horizon Surgical SystemsOct 2024Series ALead
ONL TherapeuticsSep 2024Series DCo-investor
VIAN TherapeuticsJun 2024SeedCo-investor

Key People

Adam Benowitz

Founding Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.